Profil
Pierre Vandepapeliere is the founder of Amyl Therapeutics SRL, serving as Chief Executive & Medical Officer since 2020.
Former positions include Director-Clinical Research at GlaxoSmithKline Biologicals SA, Chief Medical Officer at Neovacs SA, Principal at AstraZeneca, Inc. in 1990, Chief Medical Officer at ImCyse SA in 2019, and Chief Medical Officer & VP-Clinical Development at Abivax SA. Education includes a doctorate from Ghent University and both undergraduate and doctorate degrees from Facultés Universitaires Notre-Dame de la Paix.
Aktiva positioner av Pierre Vandepapeliere
| Företag | Position | Start |
|---|---|---|
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Operates as a preclinical biotechnology company | Verkställande Direktör | 2020-01-01 |
Tidigare kända positioner av Pierre Vandepapeliere
| Företag | Position | Slut |
|---|---|---|
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Verkställande Direktör | 2019-08-07 |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Företagsledare/Principal | 1990-12-31 |
| ABIVAX | Teknisk/Vetenskaplig/F&U Direktör | - |
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Teknisk/Vetenskaplig/F&U Direktör | - |
| NEOVACS | Teknisk/Vetenskaplig/F&U Direktör | - |
Pierre Vandepapelieres utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
GlaxoSmithKline Biologicals SA
GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Health Technology |
Neovacs SA
Neovacs SA Pharmaceuticals: MajorHealth Technology Discovers and develops antibody therapies | Health Technology |
Ghent University
Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Facultés Universitaires Notre-Dame de la Paix
Facultés Universitaires Notre-Dame de la Paix Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
ImCyse SA
ImCyse SA BiotechnologyHealth Technology Engages in the development of curative therapies in the field of immune and allergic pathologies | Health Technology |
Abivax SA
Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Amyl Therapeutics SRL
Amyl Therapeutics SRL BiotechnologyHealth Technology Operates as a preclinical biotechnology company | Health Technology |
















